Breast Cancer Research (Mar 2021)
Correction to: Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent
Abstract
An amendment to this paper has been published and can be accessed via the original article.
